首页 › 基金 › SILVERARC CAPITAL MANAGEMENT, LLC › CGEN
SILVERARC CAPITAL MANAGEMENT, LLC 对 CGEN 的持仓历史
COMPUGEN LTD · 医疗保健
SILVERARC CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 CGEN(COMPUGEN LTD)3,586,785 股,市值约 US$8.5M,约占其申报组合的 1.09%,在其申报持仓中市值排名第 28 位。 SILVERARC CAPITAL MANAGEMENT, LLC 最近 13 个申报季度中有 13 个季度披露了 CGEN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLC 对 CGEN 的持仓演变
SILVERARC CAPITAL MANAGEMENT, LLC 于 Q3 2023 首次披露 CGEN 持仓:350,188 股(约 US$326K)。 该持仓在 Q3 2026 达到峰值 3,586,785 股,市值约 US$8.5M。 在 13 次申报中,SILVERARC CAPITAL MANAGEMENT, LLC 9 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 3,586,785 股、市值约 US$8.5M,环比增持 402,528 股。。 持仓曾出现大幅变动:Q4 2023 增持约 168% (随后一个季度股价上涨 30%)、Q2 2024 增持约 50% (随后一个季度股价上涨 8%)、Q1 2025 增持约 78% (随后一个季度股价上涨 22%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 350.19K | $325.68K | 新进 |
| Q4 2023 | 940.00K | $1.86M | 增持 |
| Q1 2024 | 1.00M | $2.58M | 增持 |
| Q2 2024 | 1.50M | $2.52M | 增持 |
| Q3 2024 | 1.50M | $2.72M | 持有 |
| Q4 2024 | 1.62M | $2.49M | 增持 |
| Q1 2025 | 2.90M | $4.23M | 增持 |
| Q2 2025 | 3.03M | $5.40M | 增持 |
| Q3 2025 | 3.31M | $4.87M | 增持 |
| Q4 2025 | 3.48M | $5.32M | 增持 |
| Q1 2026 | 3.32M | $7.06M | 减持 |
| Q2 2026 | 3.18M | $6.81M | 减持 |
| Q3 2026 | 3.59M | $8.54M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGEN 与 13F 数据
CGEN(COMPUGEN LTD)属于医疗保健行业。我们追踪的基金中还有 25 只申报持有 CGEN,申报仓位最大的包括:Taylor Frigon Capital Management LLC (US$1.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 SILVERARC CAPITAL MANAGEMENT, LLC
常见问题
How long has SILVERARC CAPITAL MANAGEMENT, LLC held CGEN?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed CGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in CGEN?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 3.59M shares of CGEN (COMPUGEN LTD), valued at $8.54M, representing 1.09% of its reported portfolio and ranking #28.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling CGEN?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in CGEN. The position peaked in Q3 2026 at 3.59M shares.
Which other funds hold CGEN?
Other major institutional holders of CGEN include Taylor Frigon Capital Management LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.